冠動脈バイパスグラフトの市場：方法、手技、製品別-2025-2030年の世界予測

冠動脈バイパスグラフト市場は、2023年に171億1,000万米ドルと評価され、2024年には181億6,000万米ドルに達すると予測され、CAGR 6.19％で成長し、2030年には260億5,000万米ドルに達すると予測されています。

冠動脈バイパスグラフト（CABG）市場は、詰まった動脈や病気の動脈に血液を振り向けることで、心臓への血流を改善する外科的処置を伴う。CABGの必要性は、世界の死亡率の主要原因である冠動脈疾患（CAD）の治療に重要な役割を果たすことから生じています。CABGの用途は主に病院や心臓センターで、患者の予後を改善するために複雑な手技が行われます。エンドユースの範囲は広く、緊急時と待機的手術の両方で急性冠動脈症状に対処します。CABG市場の主な成長要因としては、高齢化や生活習慣に関連した危険因子によるCADの有病率の増加、手術手技の進歩、合成や組織工学的オプションのような移植片材料の革新などが挙げられます。低侵襲手術に対する需要の高まりは、回復時間を短縮し患者の経験を向上させることができるため、潜在的な機会となっています。戦略的な提言としては、新規の移植材料や技術を開発するための研究開発への投資、新興国市場への進出、より良いアウトリーチのためのヘルスケアプロバイダーとのパートナーシップの形成などがあります。しかし、同市場は、手技にかかる費用の高さ、規制上の課題、血管形成術やステント留置術のような代替治療の利用可能性など、成長軌道に影響を及ぼす可能性のある限界に直面しています。これらの課題に対処するには、コスト削減戦略に焦点を当て、CABGの利点を強調するために患者教育を改善する必要があります。技術革新が必要な分野には、より耐久性が高く生体適合性の高いグラフト材料の開発や、ロボット支援手術の進歩などがあります。さらに、ビッグデータとAIを活用することで、治療を調整したり合併症を予測したりすることで、患者の転帰を向上させることができます。同市場は、既存プレーヤーと技術的ブレークスルーに注力する新規参入者の両方が存在し、競争が続いています。成功するためには、企業は技術的進歩、コスト効率、戦略的提携に焦点を当て、進化する状況を乗り切る必要があります。

市場力学：急速に進化する冠動脈バイパスグラフト市場の主要市場インサイトを公開

冠動脈バイパスグラフト市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 冠動脈疾患の有病率の増加
  • ヘルスケア支出の増加と心臓専門医療センターの増加
  • CABG手術に対する有利な償還政策
• 市場抑制要因
  • CABG手術の合併症やリスクに関する懸念
• 市場機会
  • ロボット支援手術などの低侵襲CABG技術の開発
  • 手術手技と画像技術の進歩
• 市場の課題
  • 冠動脈疾患予防のための代替技術の利用可能性

ポーターの5つの力：冠動脈バイパスグラフト市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：冠動脈バイパスグラフト市場における外部からの影響の把握

外部マクロ環境要因は、冠動脈バイパスグラフト市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析冠動脈バイパスグラフト市場における競合情勢の把握

冠動脈バイパスグラフト市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス冠動脈バイパスグラフト市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、冠動脈バイパスグラフト市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨冠動脈バイパスグラフト市場における成功への道筋を描く

冠動脈バイパスグラフト市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 冠動脈疾患の罹患率の増加
    • ヘルスケア費の増加と心臓専門センターの増加
    • CABG手術に対する有利な償還ポリシー
  • 抑制要因
    • CABG手術に伴う合併症とリスクに関する懸念
  • 機会
    • ロボット支援手術などの低侵襲CABG技術の開発
    • 外科手術技術と画像技術の進歩
  • 課題
    • 冠動脈疾患の予防のための代替技術の利用可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 冠動脈バイパスグラフトの市場：方法別

• 低侵襲直接CABG
• オフポンプ
• オンポンプ

第7章 冠動脈バイパスグラフトの市場手順別

• ダブルCABG手術
• 4回CABG手術
• シングルCABG手術
• トリプルCABG手術

第8章 冠動脈バイパスグラフトの市場：製品別

• 胃大網動脈
• 内胸動脈移植
• 橈骨動脈
• 伏在静脈移植

第9章 南北アメリカの冠動脈バイパスグラフトの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の冠動脈バイパスグラフトの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの冠動脈バイパスグラフトの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AtriCure, Inc.
• Boston Scientific Corporation
• Edwards Lifesciences
• enVVeno Medical Corporation
• Genesee Biomedical Inc.
• Getinge AB
• KARL STORZ SE & Co. KG
• Medtronic PLC
• Peters Surgical
• Scanlan International, Inc.
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Transonic Systems Inc.
• Vascular Graft Solutions Ltd.

LIST OF FIGURES

• FIGURE 1. CORONARY ARTERY BYPASS GRAFTS MARKET RESEARCH PROCESS
• FIGURE 2. CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CORONARY ARTERY BYPASS GRAFTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CORONARY ARTERY BYPASS GRAFTS MARKET DYNAMICS
• TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE DIRECT CABG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY DOUBLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY QUADRUPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY TRIPLE CABG SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GASTROEPIPLOIC ARTERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY INTERNAL THORACIC ARTERY GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SAPHENOUS VEIN GRAFTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 49. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 52. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 104. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 116. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 119. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

The Coronary Artery Bypass Grafts Market was valued at USD 17.11 billion in 2023, expected to reach USD 18.16 billion in 2024, and is projected to grow at a CAGR of 6.19%, to USD 26.05 billion by 2030.

The coronary artery bypass grafts (CABG) market involves surgical procedures used to improve blood flow to the heart by redirecting blood around clogged or diseased arteries. The necessity of CABG arises from its critical role in treating coronary artery disease (CAD), a leading cause of mortality globally. Its application is primarily in hospitals and cardiac centers, where complex procedures are performed to improve patient outcomes. End-use scope is broad, addressing acute coronary symptoms in both emergency situations and elective surgeries. Key growth factors in the CABG market include the increasing prevalence of CAD due to aging populations and lifestyle-related risk factors, advancements in surgical techniques, and innovations in graft materials like synthetic and tissue-engineered options. The growing demand for minimally invasive procedures represents a potential opportunity, as it can reduce recovery times and improve patient experiences. Strategic recommendations include investing in R&D for developing novel graft materials and techniques, expanding into emerging markets, and forming partnerships with healthcare providers for better outreach. However, the market faces limitations such as the high cost of procedures, regulatory challenges, and the availability of alternative treatments like angioplasty and stenting that might affect the growth trajectory. Addressing these challenges requires a focus on cost-reduction strategies and improved patient education to highlight the benefits of CABG. Areas ripe for innovation include the development of more durable and biocompatible graft materials, as well as advancements in robotic-assisted surgeries. Additionally, big data and AI can be leveraged to enhance patient outcomes by tailoring treatments and predicting complications. The market remains competitive, characterized by both established players and new entrants focusing on technological breakthroughs. To succeed, businesses must maintain a keen focus on technological advancements, cost-efficiency, and strategic collaborations to navigate the evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coronary Artery Bypass Grafts Market

The Coronary Artery Bypass Grafts Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of coronary artery diseases
  • Rising healthcare expenditure and growing number of cardiac specialty centers
  • Favorable reimbursement policies for CABG surgery
• Market Restraints
  • Concerns associated with complications and risk of CABG surgery
• Market Opportunities
  • Development of minimally invasive CABG techniques such as robotic-assisted surgery
  • Advancements in surgical techniques and imaging technologies
• Market Challenges
  • Availability of alternate technologies for prevention of coronary artery diseases

Porter's Five Forces: A Strategic Tool for Navigating the Coronary Artery Bypass Grafts Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coronary Artery Bypass Grafts Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coronary Artery Bypass Grafts Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coronary Artery Bypass Grafts Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coronary Artery Bypass Grafts Market

A detailed market share analysis in the Coronary Artery Bypass Grafts Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coronary Artery Bypass Grafts Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coronary Artery Bypass Grafts Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coronary Artery Bypass Grafts Market

A strategic analysis of the Coronary Artery Bypass Grafts Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Bypass Grafts Market, highlighting leading vendors and their innovative profiles. These include AtriCure, Inc., Boston Scientific Corporation, Edwards Lifesciences, enVVeno Medical Corporation, Genesee Biomedical Inc., Getinge AB, KARL STORZ SE & Co. KG, Medtronic PLC, Peters Surgical, Scanlan International, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Transonic Systems Inc., and Vascular Graft Solutions Ltd..

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Bypass Grafts Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Method, market is studied across Minimally Invasive Direct CABG, Off-Pump, and On-Pump.
• Based on Procedure, market is studied across Double CABG Surgery, Quadruple CABG Surgery, Single CABG Surgery, and Triple CABG Surgery.
• Based on Product, market is studied across Gastroepiploic Artery, Internal Thoracic Artery Grafts, Radial Artery, and Saphenous Vein Grafts.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of coronary artery diseases
    • 5.1.1.2. Rising healthcare expenditure and growing number of cardiac specialty centers
    • 5.1.1.3. Favorable reimbursement policies for CABG surgery
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns associated with complications and risk of CABG surgery
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of minimally invasive CABG techniques such as robotic-assisted surgery
    • 5.1.3.2. Advancements in surgical techniques and imaging technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternate technologies for prevention of coronary artery diseases
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Coronary Artery Bypass Grafts Market, by Method

• 6.1. Introduction
• 6.2. Minimally Invasive Direct CABG
• 6.3. Off-Pump
• 6.4. On-Pump

7. Coronary Artery Bypass Grafts Market, by Procedure

• 7.1. Introduction
• 7.2. Double CABG Surgery
• 7.3. Quadruple CABG Surgery
• 7.4. Single CABG Surgery
• 7.5. Triple CABG Surgery

8. Coronary Artery Bypass Grafts Market, by Product

• 8.1. Introduction
• 8.2. Gastroepiploic Artery
• 8.3. Internal Thoracic Artery Grafts
• 8.4. Radial Artery
• 8.5. Saphenous Vein Grafts

9. Americas Coronary Artery Bypass Grafts Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Coronary Artery Bypass Grafts Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Coronary Artery Bypass Grafts Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AtriCure, Inc.
• 2. Boston Scientific Corporation
• 3. Edwards Lifesciences
• 4. enVVeno Medical Corporation
• 5. Genesee Biomedical Inc.
• 6. Getinge AB
• 7. KARL STORZ SE & Co. KG
• 8. Medtronic PLC
• 9. Peters Surgical
• 10. Scanlan International, Inc.
• 11. Stryker Corporation
• 12. Teleflex Incorporated
• 13. Terumo Corporation
• 14. Transonic Systems Inc.
• 15. Vascular Graft Solutions Ltd.